Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 1 Apr 24 S-8 POS Registration of securities for employees (post-effective amendment)
-
10 Mar 22 S-8 Registration of securities for employees
EIGRQ similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 10, 2022, with respect to the consolidated financial statements of Eiger BioPharmaceuticals, Inc., incorporated herein by reference.
/s/ KPMG LLP
San Francisco, California
March 10, 2022